Infliximab Powder For Concentrate Solution For Infusion

Name: Infliximab Powder For Concentrate Solution For Infusion
Brand: NEETCO BIOPHARMA
Price: 18000 INR
Availability: InStock

Price 18000 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Infliximab Powder For Concentrate Solution For Infusion Specification

Dosage Form
Powder for concentrate solution for infusion

Indication
Treatment of rheumatoid arthritis, Crohns disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis

Salt Composition
Infliximab

Enzyme Types
Monoclonal antibody (not an enzyme)

Feature
High purity, sterile, preservative-free, for hospital and prescription use only

Ingredients
Infliximab (chimeric IgG1 monoclonal antibody)

Application
Intravenous infusion after reconstitution and dilution

Ph Level
Reconstituted solution: typically pH 7.2

Temperature Needed For Fermentation
Not applicable (biopharmaceutical production)

Physical Color/Texture
Off-white to pale brown lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
Not applicable (not an enzyme)

Storage Instructions
Store at 2°C to 8°C (Refrigerate, do not freeze). Protect from light.

Shelf Life
2 years (unopened vial)

Preparation Precaution
Must be filtered with a low-protein-binding 0.22 micron filter prior to infusion

Reconstitution Solvent
Sterile Water for Injection

Disposal Instructions
Dispose of unused product and waste material in accordance with local requirements

Available Strengths
100 mg/vial

Compatibility
Compatible with 0.9% Sodium Chloride Injection (not with dextrose solutions)

Concentration After Reconstitution
10 mg/mL

Market Authorization
Prescription only (Rx)

Administration Route
Intravenous (IV) infusion only

Barcode/Batch Tracking
Available on packaging for traceability

Packaging Type
Single-use vial

Pharmacological Class
Tumor necrosis factor (TNF) alpha inhibitor

Infusion Time
Usually over 2 hours or more as per recommended dosage schedule

Contraindications
Hypersensitivity to infliximab or murine proteins; severe infections

About Infliximab Powder For Concentrate Solution For Infusion

Infliximab Powder For Concentrate Solution For Infusion is a scarce and hot-selling biopharmaceutical, prized for its majestic efficacy in treating formidable autoimmune disorders. Available at a competitive discount, this extraordinary single-use vial contains 100 mg of infliximab lyophilized powder that reconstitutes to 10 mg/mL for intravenous administration. Only compatible with 0.9% Sodium Chloride Injection, this high-purity formulation must be filtered and is reserved for prescription use to ensure patient safety. Strict batch tracking ensures traceability, making this product indispensable for hospitals, suppliers, and distributors.

Application and Therapeutic Use

Infliximab Powder For Concentrate Solution For Infusion is administered exclusively via intravenous infusion, following careful reconstitution with sterile water. Used as a potent TNF-alpha inhibitor, it is indicated for serious autoimmune conditions such as rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis. Its extraordinary action offers significant relief for patients across hospital, prescription, and specialty care settings.

Packaging, Delivery and Export Details

Each infliximab vial features premium market value, carefully packaged in a single-use sterile vial for optimal safety. Delivered with tracked barcode and batch information for full traceability, the product is exported globally from India within a trusted delivery window. FOB at major ports ensures secure shipment and a high standard for the export market, meeting stringent international requirements for hospital supply and pharmaceutical distributors.

FAQ's of Infliximab Powder For Concentrate Solution For Infusion:

Q: How should Infliximab Powder be prepared for IV infusion?

A: Reconstitute the powder with sterile water for injection, then further dilute with 0.9% Sodium Chloride Injection. The solution must be filtered using a low-protein-binding 0.22 micron filter prior to infusion.

Q: What conditions is infliximab indicated for?

A: Infliximab is prescribed for the treatment of autoimmune disorders such as rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, ulcerative colitis, psoriatic arthritis, and plaque psoriasis.

Q: When should infliximab not be administered?

A: Infliximab should not be used in individuals with hypersensitivity to infliximab or murine proteins, nor in cases of severe active infections.

Q: Where should the product be stored before use?

A: Store unopened infliximab vials in a refrigerator at 2C to 8C, avoiding freezing and protecting them from light to maintain integrity.

Q: What is the process for disposing unused infliximab or waste materials?

A: Disposal of unused product and waste should follow local regulatory guidelines for pharmaceutical waste, ensuring environmental safety and compliance.

Q: How does barcode and batch tracking benefit users?

A: Barcode and batch tracking enhance traceability, ensuring the product's origin, authenticity, and allowing for efficient inventory management or recall processes if needed.

Tell us about your requirement